Iran Pharmaceutical Market Access and Registration Pathway

AI Citation Summary

• Country: Iran Pharmaceutical Market Access and Registration Pathway
• Product line: Pharmaceuticals
• Regulator / source: Regulatory maturity: Medium-high but operationally complex. Iran Food and Drug Administration (IFDA) / Food and Drug Organization (FDO), under the Ministry of Health and Medical Education (MOHME), shape product registration, importation, pricing, traceability, and post-market duties.
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
• Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
• Local requirement: Local Market and Importer Map
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Market profile: Iran is one of the larger pharmaceutical markets in the Middle East. Local generic capability is strong, while imported products tend to concentrate around innovative medicines, specialty products, biologics, plasma-derived medicinal products, shortage medicines, and products not reliably supplied by local manufacturers.
• Regulatory maturity: Medium-high but operationally complex. Iran Food and Drug Administration (IFDA) / Food and Drug Organization (FDO), under the Ministry of Health and Medical Education (MOHME), shape product registration, importation, pricing, traceability, and post-market duties.
• Core decision: Iran entry is not simply a distributor search. A project must assess local substitutes, authorised agent control, Iran Registration Code (IRC), pricing approval, import permission, distribution channels, payment path, and sanctions compliance together.

Regulator

• Regulatory system: Iran Food and Drug Administration (IFDA) / Food and Drug Organization (FDO), under Ministry of Health and Medical Education (MOHME)
• Key concepts: Product License Holder (PLH), Marketing Authorization Holder (MAH), Authorized Agent, Marketing Authorization License, Iran Registration Code (IRC), Responsible Pharmacist, Iran Drug List, TTAC traceability
• Commercial boundary: Iran-related pharmaceutical transactions can require sanctions and counterparty screening. Humanitarian or medicine-related authorisations do not replace checks on the counterparty, bank, end user, product use, and transaction structure.

Local Market and Importer Map

Iranian pharmaceutical importers can be grouped into three practical categories:

Type	Main function	Typical product fit
Large registration / import / promotion companies	Represent foreign products for registration, import, pricing interaction, hospitals, and specialty channels	Innovative drugs, specialty drugs, complex dosage forms, multinational brands
Specialty medicine / biologic / plasma-product importers	Handle cold chain, hospital access, blood products, rare diseases, and high-complexity supply chains	Oncology, immunology, plasma-derived medicinal products, rare disease products, renal and transplant medicines
API / local manufacturing / under-license partners	Support local production, technology transfer, contract manufacturing, complex generics, and biosimilars	Generics, complex generics, biosimilars, long-term supply-security projects

The following company pool comes from local market research and public company signals. It is a BD and counterparty-screening starting point, not a fully verified ranking table:

Company	Chinese label	Initial positioning	Possible engagement direction
Behestan Darou	贝赫斯坦药业	Innovative and specialty-drug registration / import / promotion platform	Oncology, immunology, rare disease, specialty chronic care, complex dosage forms
Cobel Darou	科贝尔药业	Prescription and specialty-drug platform connected with multinational companies	Cardiovascular, diabetes, oncology, respiratory, renal care, vaccines
Shafayab Gostar	沙法亚布	Innovative drug registration, import and distribution	Innovative medicines, hospital specialty products, multinational brand agency
Darman Ara	达尔曼阿拉	Plasma products, biologics, medical nutrition, and adjacent medical products	Albumin, immunoglobulin, coagulation factors, biologics
Behestan Plasma	贝赫斯坦血浆	PDMP / plasma-derived medicinal products	Plasma products, rare disease and hematology products
Ahran Tejarat	阿赫兰贸易	Import, distribution, agency, and partial local manufacturing	Women's health, nephrology, orthopedics, urology, CNS, supplements
Actoverco	阿克托沃	Local manufacturer with import, generic, and biosimilar capabilities	Local production, technology transfer, complex generics
Tose'e Amin Darou Arad / TADA	阿明达鲁阿拉德	Registration, import, contract manufacturing, and local production	Smaller market-entry and localisation projects
Novo Nordisk Pars	诺和诺德伊朗公司	Local multinational affiliate	Diabetes, insulin, GLP-1; usually not a third-party agency target
Rougine / Rojin Darou / Plasma	鲁金 / 罗金系	Import, plasma, or local-manufacturing related business	Specialty medicines, plasma products, under-license products

Registration Pathway

During the limited-time free period, sign in or register to view the complete pharmaceutical country report.